0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Vigabatrin sachet:

Vigabatrin sachet 500mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Vigabatrin:

  • Anguilla
  • Azerbaijan
  • Bahrain
  • Belize
  • Brazil
  • Costa Rica
  • Croatia
  • Ecuador
  • El Salvador
  • Fiji
  • Germany
  • Gibraltar
  • Guadeloupe
  • Guatemala
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iraq
  • Kuwait
  • Lebanon
  • Liechtenstein
  • Moldova, Republic of
  • Monaco
  • Netherlands
  • Netherlands Antilles
  • Qatar
  • Russian Federation
  • Saint Lucia
  • Seychelles
  • Slovakia
  • Sweden
  • Thailand
  • Tonga
  • Trinidad and Tobago
  • Turkey
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
View All Countries

Latest news releases on Vigabatrin:

Catalyst Pharmaceutical Partners Announces Completion of Enrollment in CPP-109 Phase II(b) Clinical Trial for the Treatment of Cocaine Addiction - Yahoo Finance

CORAL GABLES, Fla., May 21, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX - News) today announced that patient enrollment in its CPP-109 vigabatrin Phase II(b) clinical trial has reached its goal of 200 cocaine ...

Catalyst Pharmaceutical Partners Reports Positive Results From Phase I(a) Clinical Study of CPP-115 - msnbc.com

CPP-115 is a novel GABA aminotransferase inhibitor and vigabatrin analogue that, based on preclinical studies to-date, is greater than 100 times more potent than vigabatrin and may have reduced side effects (e.g., visual field defects ...

Catalyst Pharmaceutical Partners Announces First Quarter 2012 Financial Results - Yahoo Finance

Catalyst has two products in development, and is currently evaluating its lead product candidate, CPP-109 (vigabatrin), for the treatment of cocaine dependency. CPP-109 has been granted "Fast Track" status by the U.S. Food & Drug Administration ...

Catalyst Pharmaceutical Partners, Inc. : Catalyst Pharmaceutical Partners Announces First Quarter 2012 Financial Results - 4-traders (press release)

Catalyst has two products in development, and is currently evaluating its lead product candidate, CPP-109 (vigabatrin), for the treatment of cocaine dependency. CPP-109 has been granted "Fast Track" status by the U.S. Food & Drug Administration (FDA ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK